Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 3NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Leukemia 4Leukemia, Myeloid, Acute 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Biphenotypic, Acute 2Recurrence 1Colorectal Neoplasms 1

Interventions

fludarabine phosphate 4fludarabine 3Mycophenolic Acid 3Filgrastim 3Cytarabine 3Cyclophosphamide 3revumenib 2Whole-Body Irradiation 2Mesna 2Bone Marrow Transplantation 2pegaspargase 1Vincristine 1Thiotepa 1Stem Cell Transplantation 1Standard of Care 1Sirolimus 1Midazolam 1Melphalan 1MRX-2843 1Itraconazole 1Granulocyte Colony-Stimulating Factor 1Fentanyl 1Dexamethasone 1Cyclosporine 1Cord Blood Stem Cell Transplantation 1Cobicistat 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Leukemia, Biphenotypic, Acute × revumenib × Clear all
NCT04065399 2026-03-18

AUGMENT-101

Syndax Pharmaceuticals

Phase 1/2 Recruiting
447 enrolled 2 FDA
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05326516 2024-08-13

A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

Syndax Pharmaceuticals

Phase 1 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡